are glp-1 safe Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity How Effective and Safe Are

In the field of research and development of multi-target receptor agonist drugs, there are currently several multi-receptor agonists under research in the world that have entered the clinical stage

While semaglutide was initially approved primarily for diabetes management, it has increasingly been prescribed off-label by weight-loss specialists due to its remarkable results in clinical trials

These associations were not seen with the long-acting GLP-1RAs in this study, though were observed from the FDA adverse events database real-world pharmacovigilance study.23 There are no specific recommendations regarding the management of reflux and associated complications in patients taking GLP-1RAs, so standard management is advised, along with consideration of dose adjustment or cessation depending on individual circumstances

doi: 10.1007/s00018-010-0398-3 126 MacQueenG.FrodlT

[PMC free article] [PubMed] [Google Scholar] 87.Bush MA, Matthews JE, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, et al